DexCom (DXCM) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2521311074

DexCom, Inc. is a leading medical device company that specializes in creating and selling continuous glucose monitoring (CGM) systems worldwide. These systems are mainly used by individuals with diabetes and healthcare professionals to monitor glucose levels constantly.

The company offers innovative products like Dexcom G6 and Dexcom G7, which are advanced integrated CGM systems tailored for efficient diabetes management. Additionally, DexCom provides solutions such as Dexcom Share for remote monitoring and Dexcom Real-Time API for seamless integration into digital health apps and devices from third-party developers.

One noteworthy product from DexCom is Dexcom ONE, which is engineered to eliminate the need for traditional finger stick blood glucose testing, making diabetes treatment decisions smoother and more accurate. On a significant note, DexCom has a pending FDA review for Dexcom Stelo, a system designed specifically for individuals with type 2 diabetes.

Furthermore, DexCom has strategic collaborations with Verily Life Sciences LLC and Verily Ireland Limited to develop cutting-edge blood-based or interstitial glucose monitoring products. The company primarily markets its products directly to endocrinologists, physicians, and diabetes educators for widespread use and accessibility.

Founded in 1999 and headquartered in San Diego, California, DexCom continues to drive innovation and set new standards in the field of continuous glucose monitoring. For more information, visit their website at

AI improved, may contain errors or wrong assumptions

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for DexCom (DXCM) - Stock Price & Dividends

DXCM Stock Overview

Market Cap in USD 48,980m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 2005-04-14

DXCM Stock Ratings

Fundamental 7.32
Dividend -
Growth 5y 5.78
Rel. Performance vs Sector -1.04
Analysts 4.59
Fair Price Total Ret. 114.46
Fair Price DCF 36.07

DXCM Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

DXCM Growth Ratios

Growth 12m 3.88%
Growth Correlation 12m -1%
Growth Correlation 3m 6%
CAGR 5y 26.26%
CAGR / Mean Drawdown 1.27
Sharpe Ratio 12m -0.03
Alpha vs SP500 12m -29.84
Beta vs SP500 5y weekly 1.16
CAPM 8.44%
Average Daily Range 2m 2.70%
Regime Oscillator 23.23
Volatility GJR Garch 1y 42.91%
Price / SMA 50 -5.99%
Price / SMA 200 2.01%
Current Volume 2269.3k
Average Volume 20d 3314k

External Links for DXCM Stock

Wall Street JournalBenzingaYahoo Finance
X (Twitter)Stocktwits
Fund Manager Positions
What is the price of DXCM stocks?
As of February 28, 2024, the stock is trading at USD 115.32 with a total of 2,269,287 shares traded.
Over the past week, the price has changed by -2.16%, over one month by -5.44%, over three months by +1.18% and over the past year by +4.29%.
Why is DXCM stock down?
Check with which Index or Commodity DXCM has the highest Correlation, do they have a common driver?
Review the Fundamentals to find weaknesses (Debt, low returns). Check the Performance of the Peer-Group to find out, if the entire sector is under pressure.
Period Return DXCM Return S&P 500
1 Month -5.44% 4.00%
3 Months 1.18% 11.99%
12 Months 4.29% 29.39%
What is the forecast for DXCM stock price target?
According to ValueRays Forecast Model, DXCM DexCom will be worth about 127.7 in February 2025. The stock is currently trading at 115.32. This means that the stock has a potential upside of +10.73%.
Issuer Forecast Upside
Wallstreet Target Price 143.4 24.3%
Analysts Target Price 137 18.8%
ValueRay Target Price 127.7 10.7%